We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Rare Cell Isolation Technique Improved

By LabMedica International staff writers
Posted on 06 Nov 2012
An innovative concept has been reported for the separation of rare cells, such as prostate cancer cells or circulating tumor cells, using microfluidics. More...


The technique allows an entire blood draw to be processed, in continuous manner, in a shorter period of time, and does not rely on antibodies, which is important because not all cancer cells express antigens.

Scientists at the University of Cincinnati ( OH, USA), used inertial microfluidics to continuously and selectively collect rare cells, such as circulating tumor cells, based on their size versus other biomarkers. The advantage of inertial microfluidics in cell separation is that it can be done easily and without cumbersome equipment. This type of work is leading to an entirely new generation of testing capabilities that particularly lend themselves to direct use in the field and in physicians' offices in just about any country and any economic setting. Another area in which this device could be useful is in working with cell cultures.

The device is essentially a clear, plastic, flexible square that is relatively small, at about 12.7 mm across. The device contains four outlet ports that separate the blood into different streams, allowing the collection of outputs containing dilute plasma, red blood cells, and white blood cells. This quick, low-cost way of running a diagnostic test could potentially be used in a resource-limited setting. Ian Papautsky, PhD, an associate professor at the College of Engineering and Applied Science (Cincinnati, OH, USA), said, "If you have a mixture of multiple cells where some cells are small and other cells are big, we could separate these cell populations very easily. Anytime you need to separate based on size, we can do it using inertial microfluidics."

Prof. Papautsky explained, “There are a lot of clinical diagnostic tests that are based on blood. One of the most common tests that are done in a hospital is the complete blood count (CBC). Through this test, a wide range of conditions like anemia, malaria or leukemia are diagnosed. In all of these diagnostic tests, blood must be separated into its components, and that's what this device does. So, instead of using a big centrifuge to do it, we can do it with this little device." The microfluidic device allows for a diagnosis in less time in a much easier fashion. The study was reported at the Sixteenth International Conference on Miniaturized Systems for Chemistry and Life Sciences (microTAS) held October 28 to November 1, 2012, in Okinawa (Japan).

Related Links:

University of Cincinnati
College of Engineering and Applied Science
microTAS


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
Gold Member
Serum Indices Control
Acusera Serum Indices Control
Hematology Consumables
Bioblood Devices
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Lead author Professor Chamindie Punyadeera. (Image Credit: Griffith University)

Breath Analysis Shows Promise for Distinguishing Cancerous from Benign Lung Nodules

Lung nodules are frequently detected during imaging, but distinguishing malignant from benign findings can require invasive procedures. Some patients undergo biopsies, bronchoscopy, or surgery before learning... Read more

Molecular Diagnostics

view channel
Image: Skin samples from people with a suspected genetic myopathy were examined for confirmation of disease. Brown spots show abnormal protein buildup inside the nuclei of cells (purple), typical of a type of myopathy called oculopharyngodistal myopathy. (Image Credit: Garvan Institute)

Long-Read Sequencing Test Identifies Genetic Causes in Inherited Muscle Disease

Inherited muscle diseases are highly heterogeneous and often progressive, leaving many patients without a molecular diagnosis despite extensive testing. Conventional assays typically target individual... Read more

Immunology

view channel
Image: Aptiva utilizes particle-based multi-analyte technology (PMAT) (Photo courtesy of Werfen)

Werfen Expands Automated APS Testing with FDA-Cleared and CE-Marked IgA Reagent

Antiphospholipid syndrome (APS) is an autoimmune disorder associated with thrombosis and pregnancy complications, but its symptoms can overlap with those of other conditions, complicating diagnosis.... Read more

Microbiology

view channel
Image: Each PhAST instrument supports random-access processing of up to four samples simultaneously, delivering a throughput of up to 12 samples per eight-hour shift. (Photo courtesy of PhAST)

FDA Clears Rapid Phenotypic Antimicrobial Susceptibility System for Positive Blood Cultures

Bloodstream infections require prompt treatment, but antimicrobial susceptibility results often lag behind a positive blood culture. Conventional testing can take another 24 to 48 hours after a culture... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.